SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and…
9 analysts rate SKIN Hold on consensus.
Consensus price target: $0.99 (-91.06% downside from $11.10)
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $300.79M | -10.02% | $-9.52M |
| 2024 | $334.29M | -16% | $-29.1M |
| 2023 | $397.99M | +8.78% | $-100.12M |
Stock data for SKIN: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics